Effect of serotonin receptor antagonists

HW Hitoshi Watanabe
TN Tatsuya Nakano
RS Ryo Saito
DA Daisuke Akasaka
KS Kazuki Saito
HO Hideki Ogasawara
TM Takeshi Minashima
KM Kohtaro Miyazawa
TK Takashi Kanaya
IT Ikuro Takakura
NI Nao Inoue
II Ikuo Ikeda
XC Xiangning Chen
MM Masato Miyake
HK Haruki Kitazawa
HS Hitoshi Shirakawa
KS Kan Sato
KT Kohji Tahara
YN Yuya Nagasawa
MR Michael T. Rose
SO Shyuichi Ohwada
KW Kouichi Watanabe
HA Hisashi Aso
request Request a Protocol
ask Ask a question
Favorite

Ketanserin (Sigma), an antagonist for 5HTR2A, was dissolved in 0.1 M HCl, diluted with PBS, and administered in a dosing volume of 0.1 mg/mouse. SB-204741 (Tocris Bioscience, Bristol, UK), an antagonist for 5HTR2B, was dissolved in DMSO, diluted with PBS such that the final concentration of DMSO was 0.1%, and administered in a dosing volume of 0.08 mg/mouse. SB-269970 (Sigma), 5HTR7 antagonist, and methysergide (Sigma), a 5HTR1, 2 and 7 antagonist, were dissolved in PBS and administered in a dosing volume of 0.6 and 0.1 mg/mouse, respectively. All antagonists were i.p. injected at 30 min before the injection of 1 mg 5-HT. After 120 min, samples were collected from skeletal muscle.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A